T4	total-participants 755 758	100
T5	eligibility 759 807	female patients undergoing breast cancer surgery
T6	control 925 932	placebo
T7	total-participants 1084 1087	100
T8	outcome 1234 1261	persistent neuropathic pain
T9	outcome 1355 1397	development of persistent neuropathic pain
T10	iv-bin-percent 1399 1404	43.1%
T11	cv-bin-percent 1408 1413	63.3%
T12	outcome 1498 1513	persistent pain
T13	iv-bin-percent 1515 1518	60%
T14	cv-bin-percent 1522 1525	46%
T1	intervention 0 62	Perioperative Pregabalin and Intraoperative Lidocaine Infusion
T2	condition 73 100	Persistent Neuropathic Pain
